These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9315348

  • 1. Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
    Talom RT, McNeill JR.
    Can J Physiol Pharmacol; 1997 Jul; 75(7):812-7. PubMed ID: 9315348
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
    Januszewicz A, Lapiński M, Styś T, Styś A, Loń S.
    Pol J Pharmacol; 1994 Jul; 46(3):153-61. PubMed ID: 8000447
    [Abstract] [Full Text] [Related]

  • 3. Effect of NG-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Styś T, Szczepańska-Sadowska E.
    J Physiol Pharmacol; 1994 Jun; 45(2):231-40. PubMed ID: 7949233
    [Abstract] [Full Text] [Related]

  • 4. Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
    Tagami M, Ikeda K, Nara Y, Fujino H, Kubota A, Numano F, Yamori Y.
    Lab Invest; 1995 Feb; 72(2):174-82. PubMed ID: 7853851
    [Abstract] [Full Text] [Related]

  • 5. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T, Berthelot A, Bouhaddi M, Laurant P, André C, Guillaume Y, Demougeot C.
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [Abstract] [Full Text] [Related]

  • 6. Effects of estrogen in the regulation of nitric oxide pathway during development of hypertension in rats.
    Doursout MF, Chelly JE.
    Proc West Pharmacol Soc; 2002 Jun; 45():49-52. PubMed ID: 12434525
    [Abstract] [Full Text] [Related]

  • 7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 8. Sympathectomy exaggerates antihypertensive effect of vasopressin withdrawal.
    Chiu EK, McNeill JR.
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H1-6. PubMed ID: 7840254
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats.
    Jablonskis LT, Howe PR.
    J Hypertens; 1995 Mar; 13(3):319-25. PubMed ID: 7622853
    [Abstract] [Full Text] [Related]

  • 13. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
    Lewis SJ, Hashmi-Hill MP, Owen JR, Sandock K, Robertson TP, Bates JN.
    Vascul Pharmacol; 2006 Jun; 44(6):476-90. PubMed ID: 16697269
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
    Liu YC, Kao SJ, Chuang IC, Chen HI.
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
    [Abstract] [Full Text] [Related]

  • 15. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J, Gadek-Michalska A, Głód R, Borycz J.
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of autonomic function in the antihypertensive effect of vasopressin withdrawal in spontaneous hypertension.
    Chiu EK, McNeill JR.
    Am J Hypertens; 1992 Mar; 5(3):187-92. PubMed ID: 1575946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pressor responsiveness to vasopressin in spontaneously hypertensive rats.
    Stepniakowski K, Lapiński M, Januszewicz A, Noszczyk B, Szczepańska-Sadowska E.
    Acta Physiol Pol; 1989 Mar; 40(2):171-82. PubMed ID: 2641416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.